My long-standing goal is to understand and quantify system-level variability in immune interactions and collective responses of lymphocyte populations including T, B and NK cells to infections, vaccines and tumor-antigens. More specifically, how the spatial and functional heterogeneity in lymphocyte populations manifest and how such heterogeneity impacts immune pathologies in chronic infections and cancers.